Business Name: | Lightlake Therapeutics Inc |
Categorized In: | |
Address: | 251 East 51st St Apartment 9c, New York City, NY 10022 |
Phone Number: | (917) 273-3611 |
Contact Person: | Roger Crystal |
NAICS Code: | 325412 |
SIC Code: | 2834 |
Business Type: | B2B & B2C |
Founding Year: | 2014 |
Employee #: | 1 to 4 |
Location Type: | Single Location |
Annual Revenue ($): | $50.000 to $99.999 |
Share This Business: | |
Similar Businesses: |
Tonix Pharmaceuticals Inc - New York City, NY 10022 Krele LLC - New York City, NY 10022 Melinta Pharmaceuticals Inc - New York City, NY 10022 Aoi Pharma Inc - New York City, NY 10022 Niobe Ventures LLC - New York City, NY 10022 Ohr Pharmaceutical Inc - New York City, NY 10022 Stemline Therapeutics Inc - New York City, NY 10022 Bristol-Myers Squibb Company - New York City, NY 10022 Forest Laboratories Inc - New York City, NY 10022 Keryx Biopharmaceuticals Inc - New York City, NY 10022 Danube Pharmaceuticals Inc - New York City, NY 10022 |
Lightlake Therapeutics Inc provides professional from its single location at the coordinates .
The company offers BOTH variables under the SIC code 2834 and NAICS code 325412, while making an annual revenue of $50.000 to $99.999 and hiring a total of 1 to 4 employees.
Founded in 2014, the company can now be visited at 251 East 51st St Apartment 9c, New York City, New York 10022 or contacted through representative Roger Crystal at (917) 273-3611.
For frequently asked questions and further inquiries about professional , get to know more about Lightlake Therapeutics Inc through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.